To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC0138 | 1(r)-(trifluoromethyl)oleyl Alcohol |
Novel potent ferroptosis inhibitor
More description
|
|
| DCC0137 | 0026-59-kk |
Novel inhibitor of the biosynthesis of DNA, RNA and proteins; Antimicrobial agent
More description
|
|
| DCC0136 | 002-04-kk |
Novel inhibitor of the biosynthesis of DNA, RNA and proteins; Antimicrobial agent
More description
|
|
| DCC0135 | [n9a]lvia |
Novel α-Conotoxin LvIA Analogue, highly selectively trgeting α3β2 nicotinic acetylcholine receptors with >2000-fold higher selectivity than LvIA
More description
|
|
| DCC0134 | [d-trp]cj-15208 |
Short-duration κ opioid receptor antagonist with weak KOR agonist activity
More description
|
|
| DCC0133 | [dmt1,5]n/ofq(1-13)-nh2 |
Novel highly potent dual NOP/mu receptor peptide agonist, exerting antitussive effects in an in vivo model of cough
More description
|
|
| DCC0132 | (z)-5-tetradecen-1-ol |
Novel ligand of the mouse orphan odorant receptor Olfr288
More description
|
|
| DCC0131 | (wrk)5 |
Novel Antimicrobial Peptide with Repeating Unit against Multidrug-Resistant Bacteria
More description
|
|
| DCC0130 | (wrk)4 |
Novel Antimicrobial Peptide with Repeating Unit against Multidrug-Resistant Bacteria
More description
|
|
| DCC0129 | (s)-syaf080 |
Novel Potent Antagonist of the Human A 2B Adenosine Receptor
More description
|
|
| DCC0128 | (s)-syaf030 |
Novel Potent Antagonist of the Human A 2B Adenosine Receptor
More description
|
|
| DCC0127 | (s)-retro-1.1 |
Novel potent inhibitor of Shiga toxin (STX) cytotoxicity
More description
|
|
| DCC0126 | (s)-pomalidomide |
Inhibitor of angiogenesis and growth of B-cell neoplasias, inducing complete regressions of Burkitt's lymphoma cell tumors
More description
|
|
| DCC0125 | (s)-ncc122 |
Potent D1 dopamine ligand
More description
|
|
| DCC0124 | (s)-nbp |
More active enantiomer of NBP; Neuroprotective agent used clinically in the acute phase of ischemic stroke, improving functional recovery and promoting angiogenesis and collateral vessel circulation
More description
|
|
| DCC0123 | (s)-gyramide A |
Novel bacterial DNA gyrase inhibitor, exhibiting antimicrobial activity and inhibiting bacterial cell division
More description
|
|
| DCC0122 | (s)-fty720 Vinylphosphonate |
Novel allosteric Sphingosine kinase 1 (SK1) inhibitor
More description
|
|
| DCC0121 | (s)-ftopm |
mGlu5 PAM, displaying intrinsic agonist activity
More description
|
|
| DCC0120 | (s)-fpopm |
Selective mGlu5 positive allosteric modulator (PAM)
More description
|
|
| DCC0119 | (s)-folcisteine |
S-Enantiomer of folcisteine, a plant growth regulator
More description
|
|
| DCC0118 | (s)-esba Hydrochloride |
Selective kynurenine aminotransferase 2 (KAT2) inhibitor
More description
|
|
| DCC0117 | (s)-desmethyl-nnc112 |
PET precursor for NNC112
More description
|
|
| DCC0116 | (s)-bambuterol |
Less active enantimer of Bambuterol
More description
|
|
| DCC0115 | (s)-azd6482 |
Potent and selective inhibitor of PI 3-kinase ß (PI3-Kß)
More description
|
|
| DCC0114 | (s)-alprenolol |
Potent beta-adrenoreceptor antagonist
More description
|
|
| DCC0113 | (s)-5-hydroxy-3',8-bis(dimethylallyl)sativanone |
Natural flavonoid from the stem bark of Bolusanthus speciosus
More description
|
|
| DCC0112 | (s)-2-mercaptohistidine |
The First Selective Orthosteric GluK3 Antagonist
More description
|
|
| DCC0111 | (s)-(+)-ncgc00161870 |
Novel potent orally available allosteric TSH receptor (TSHR) agonist
More description
|
|
| DCC0110 | (rs)-ppcc Oxalate |
Novel σ Receptor Agonist with Neuroprotective Effect
More description
|
|
| DCC0109 | (r)-ß-lysine |
Elongation factor P (EF-P) fuction modifier
More description
|
|
